Privia Health Group (PRVA) Projected to Post Earnings on Thursday

Privia Health Group (NASDAQ:PRVA - Get Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $422.01 million for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.

Privia Health Group Stock Down 0.5 %

NASDAQ:PRVA traded down $0.12 on Friday, reaching $24.52. 670,281 shares of the company's stock traded hands, compared to its average volume of 599,111. The stock has a 50-day simple moving average of $21.99 and a 200-day simple moving average of $20.40. The firm has a market cap of $2.94 billion, a PE ratio of 245.22, a P/E/G ratio of 3.59 and a beta of 0.87. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $25.67.

Analysts Set New Price Targets

PRVA has been the topic of a number of recent analyst reports. Stephens reissued an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Needham & Company LLC initiated coverage on Privia Health Group in a report on Friday, January 10th. They set a "buy" rating and a $25.00 price target on the stock. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They set an "outperform" rating and a $25.00 price target on the stock. JMP Securities reissued a "market outperform" rating and set a $26.00 price target on shares of Privia Health Group in a report on Friday, February 14th. Finally, JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a report on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $24.94.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.